While the number of patients with diabetes has continuously increased worldwide, current treatment methods (self-injection of insulin) are unfavorable due to inherent issues of injectable formulations, such as immune reactions, infections, pain, and discomfort [3–5]. Here, INS is linked to diabetes mellitus.